Neurologic and Metabolic Disorders It may also serve as adjunctive therapy in: Chronic fatigue syndromes Diabetic neuropathy Insulin resistance or metabolic syndrome Age-related mitochondrial decline Dosing and Administration Route : IM injection (preferred for general use), IV infusion (under clinical guidance) Typical IM dose : 5001,000 mg, 13 times per week IV use : 12 grams diluted in compatible carrier solution (e.g., saline), infused over 3060 minutes Dosing frequency is patient-specific and may be adjusted based on clinical response , exercise load , or lab values Safety and Considerations L-Carnitine is generally well tolerated when administered properly
Urinary tract infections can also occur
This momentum has also intensified competition among pharmaceutical companies seeking to expand their presence in the fast-growing obesity and cardiometabolic market
Compounded medications dont go through this process, regardless of how similar they may appear to the commercially available medication
[DOI] [PubMed] [Google Scholar] Wang M., Ling L., Wang S., Ding C
Recommend switching to a non-oral contraceptive or adding a barrier method for 4 weeks after starting or increasing the dose